Target intelligence / Profile preview

Excitatory neurotransmission in central nervous system

Molecular classification
Other
01

Overview

"Excitatory neurotransmission in the central nervous system" is not a specific molecule or receptor but rather describes a physiological process involving multiple molecules and receptors. This process refers to the transmission of signals between neurons that increase the likelihood of generating an action potential in the postsynaptic neuron, primarily mediated by excitatory neurotransmitters such as glutamate[1][3][4][5]. Glutamate acts on various ionotropic and metabotropic receptors to facilitate depolarization and neural signaling[4][5]. Dysregulation of excitatory neurotransmission is implicated in several neurological diseases, including neurodegenerative disorders and epilepsy[4]. However, this term does not refer to a single therapeutic target or molecular entity; instead, it encompasses a broad class of synaptic mechanisms and associated proteins. For structured data purposes, more specific targets within this pathway—such as "Glutamate receptor," "SLC1A3 (glutamate transporter)," or individual ion channels—should be used instead[2][4].\n\n**Note:** The entry is too broad for use as a canonical drug target; it should be replaced with specific molecular entities involved in excitatory neurotransmission.

02

Biological functions

Signal transductionSynaptic transmissionNeural communication
03

Disease associations

Neurodegenerative diseaseEpilepsyPsychiatric disorders (e.g., depression, schizophrenia)Other

Beyond the preview

Go deeper on Excitatory neurotransmission in central nervous system.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Excitatory neurotransmission in central nervous system.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call